Table 1_Mapping the knowledge landscape of Pseudomonas aeruginosa biofilm-mediated drug re

6,537 publications and 24 clinical studies provide a data-driven overview of research on Pseudomonas aeruginosa biofilm-mediated drug resistance. The analysis maps global research output, international collaboration networks, and three major research directions from 2014 to 2025. Author Peng Zhao compiled this bibliometric and clinical trial landscape overview, last updated in June 2026.

Use Cases

• Analyze global research trends and hotspots based on the bibliometric analysis of 6,537 publications.
• Map international collaboration networks based on country-level productivity data.
• Identify emerging translational research directions based on keyword clustering and temporal analyses.
• Assess the clinical trial landscape for anti-biofilm strategies based on the review of 18 registered interventional trials.

Strengths

• Includes a substantial corpus of 6,537 publications for bibliometric analysis.
• Covers a defined 12-year time range from 2014 to 2025.
• Complements bibliometric findings with a review of 6 published clinical studies and 18 registered trials.
• Identifies specific research directions such as multidrug resistance evolution and novel antibacterial interventions.

Limitations

• Row count and column-level documentation are unknown, limiting suitability assessment.
• The dataset is very small at 21.6 KB, indicating limited scope.
• Data may reflect geographic or source bias inherent to the Web of Science and Scopus databases used.

Provenance

Source

Publications retrieved from Web of Science Core Collection and Scopus; clinical studies from trial registries.

Collection Method

Bibliometric analysis and supplementary narrative review of clinical studies.

Time Range

2014-2025

Freshness

Last updated 2026-06-01 04:21:14; freshness should be verified.

Geography

Global, with specific mention of China, the United States, and India as most productive.